GlassScriptPhysician profile
Loralie D Moeller
NPI 1174563878
$2,650.41
in general payments reported to CMS, 2019-2025
37 companies · $428 in 2025
The $428 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $278 · 2021: $456 · 2022: $619 · 2023: $233 · 2024: $113 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.38 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $282.73 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $217.99 | 2021-2025 | |
| Exeltis, USA INC. | $140.78 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $126.88 | 2019-2022 | |
| Coopersurgical, INC. | $116.37 | 2019-2022 | |
| Channel Medsystems, INC. | $109.20 | 2022 | |
| Sage Therapeutics, LLC | $101.77 | 2024-2025 | Zurzuvae |
| Biohaven Pharmaceutical Holding Company LTD. | $94.58 | 2022 | |
| Medtronic, INC. | $83.77 | 2022-2023 | Ligasure |
| Baxter Healthcare | $79.94 | 2023-2025 | Tisseel, Perclot |
| Hologic Sales and Service, LLC | $78.31 | 2019-2022 | |
| Allergan, INC. | $73.29 | 2019-2021 | |
| Astellas Pharma US INC | $56.70 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $56.44 | 2019-2025 | Gardasil 9 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $36.42 | 2024-2025 | Nexplanon |
| Roche Diagnostics Corporation | $33.74 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $32.98 | 2019 | |
| Avion Pharmaceuticals | $23.37 | 2022 | |
| Lupin INC. | $23.22 | 2019 | |
| Supernus Pharmaceuticals, INC. | $23.21 | 2025 | Qelbree |
| Radius Health, INC. | $23.00 | 2019 | |
| Ibsa Pharma INC. | $22.79 | 2020 | |
| Daiichi Sankyo INC. | $21.96 | 2021 | |
| Myovant Sciences INC. | $21.62 | 2022 | |
| Covidien LP | $20.66 | 2019 | |
| Alfasigma USA, INC. | $20.61 | 2022 | |
| Laborie Medical Technologies Corp. | $20.06 | 2024 | |
| Sumitomo Pharma America, INC. | $18.65 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $18.13 | 2019 | |
| Ascend Therapeutics US, LLC | $17.60 | 2020 | |
| Avanos Medical | $16.60 | 2019 | |
| Ethicon US, LLC | $15.54 | 2021 | |
| Agile Therapeutics, INC. | $13.57 | 2021 | |
| Lilly USA, LLC | $12.89 | 2021 | |
| Medicem INC. | $12.53 | 2022 | |
| Zyla Life Sciences, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loralie Moeller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.